Dopamine D<sub>1</sub> receptor ligands: Where are we now and where are we going.
- Published in:
- Medicinal Research Reviews, 2009, v. 29, n. 2, p. 272, doi. 10.1002/med.20130
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2009 AND VI 29 AND IP 2
Results: 5
1
2
α<sub>2</sub>-Agonists as analgesic agents.
- Published in:
- Medicinal Research Reviews, 2009, v. 29, n. 2, p. 339, doi. 10.1002/med.20134
- By:
- Publication type:
- Article
3
HIV entry inhibitors and their potential in HIV therapy.
- Published in:
- Medicinal Research Reviews, 2009, v. 29, n. 2, p. 369, doi. 10.1002/med.20138
- By:
- Publication type:
- Article
4
Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease.
- Published in:
- Medicinal Research Reviews, 2009, v. 29, n. 2, p. 295, doi. 10.1002/med.20132
- By:
- Publication type:
- Article
5
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.
- Published in:
- Medicinal Research Reviews, 2009, v. 29, n. 2, p. 213, doi. 10.1002/med.20135
- By:
- Publication type:
- Article